Clinical Observation of the Interventional Therapy for Liver Hemangioma: 37 Cases Report
Tang Dai-rong
Abstract
Tang Dai-rong
Abstract
Objective To observe the clinical effect of percutaneous hepatic artery superselective catheterization and embolization for liver hemangioma.Method 37 patients of liver hemangioma were performed superselective catheterization and embolization via hepatic artery with ultra-fluid lipiodol and bleomycin A5.Results 31 cases were embolized one time and the other 6 cases twice.During the 2 to 12 months follow-up,the tumor size was reduced more than 50% in 21 cases,20%~50% in 9 cases,and less than 20% in 7 cases without serious complication.Conclusion The percutaneous hepatic artery super-selective embolization by ultra-fluid lipiodol and bleomycin A5 is an effective therapy for liver hemangioma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the clinical effect of percutaneous hepatic artery superselective catheterization and embolization for liver hemangioma.Method 37 patients of liver hemangioma were performed superselective catheterization and embolization via hepatic artery with ultra-fluid lipiodol and bleomycin A5.Results 31 cases were embolized one time and the other 6 cases twice.During the 2 to 12 months follow-up,the tumor size was reduced more than 50% in 21 cases,20%~50% in 9 cases,and less than 20% in 7 cases without serious complication.Conclusion The percutaneous hepatic artery super-selective embolization by ultra-fluid lipiodol and bleomycin A5 is an effective therapy for liver hemangioma.
Key concepts: Medicine, Lipiodol, Embolization, Percutaneous, Hemangioma, Liver Hemangioma, Radiology, Bleomycin